| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.056 | 0.8 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |